The International Pharmaceutical Regulators Forum’s (IPRF) Biosimilars Working Group (BWG) on Tuesday released a reflection paper outlining principles that regulators around the world can use for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results